Device Trial Radar · NCT06385249
An Evaluation of Navina Mini, a New Trans-anal Irrigation (TAI) Device in Children and Adolescents
Last checked: Nov 21, 2026Latest source record: Sep 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
27
Actual
Start
Apr 3, 2024
Primary completion
Jul 9, 2025
Study completion Jul 9, 2025
Sponsor
- Lead sponsor
- Wellspect HealthCareNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 26, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 3 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is designed to deliver further information on clinical benefit, patients' satisfaction, and perception of handling and to confirm safety of Navina Mini when used in children and adolescents.
Conditions
- Bowel Dysfunction
Interventions
Navina MiniDevice
Trans-anal irrigation (TAI) with a new CE-marked device, Navina Mini
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall patient satisfactionTime frame: up to 6 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
H.K.H. Kronprinsessan Victorias Barn- och ungdomssjukhus Universitetssjukhuset
Linköping, Sweden
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.